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Alternative antimicrobials: the properties of fatty acids and 
monoglycerides. 
With the rising antibiotic resistance of many bacterial species, alternative 
treatments are necessary to combat infectious diseases. The World Health 
Organisation and the U.S. Centers for Disease Control and Prevention have 
warned that some infections, such as those from Neisseria gonorrhoeae, may be 
untreatable within a few years. One avenue of exploration is the use of 
antimicrobial fatty acids and their derivatives for therapeutic prevention or 
treatment of bacterial infections. Several studies have explored the activity of 
fatty acids and their derivatives, including monoglycerides against a variety of 
bacterial species. These are reviewed here, assessing the antimicrobial properties 
that have been demonstrated and the feasibility of therapeutic applications. 
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Introduction 
Antibiotics have saved countless lives since they were introduced, yet the spread of 
bacterial resistances to antibiotics necessitates investigations into other prophylaxis and 
treatment options. Fatty acids and there derivatives may be alternative antimicrobials 
worthy of investigation for the post-antibiotic era. The antimicrobial activity of fatty 
acids and monoglycerides has been known for over 100 years (Lamar 1911), yet the 
urgent need to identify alternatives in the face of growing antibiotic resistance is driving 
increased research in this field. 
Fatty acids are amphiphilic molecules made up of saturated or unsaturated 
carbon chains attached to a carboxyl group. The carboxyl group is hydrophilic, while 
the carbon chain is hydrophobic. This gives the molecule its amphiphilic nature and 
means that fatty acids can act at an interface between polar and non-polar liquids to 
lower surface tension. The aqueous solubility of fatty acids is determined by the length 
of the non-polar carbon chain; the longer the chain the less water soluble the molecule.  
Fatty acids are present in all living things. In naturally occurring fatty acids, the number 
of carbons in the chain is usually a multiple of two, however, fatty acids with an odd 
number of carbons can be manufactured artificially. 
Fatty acids are usually found either attached to a glycerol or a sphingosine 
molecule. Attached to each alcohol group on the glycerol are three fatty acids forming a 
triglyceride, which is important for energy storage. When broken down by lipases, the 
components are released, generating diglycerides, monoglycerides, glycerol and fatty 
acids. Phospholipids and glycolipids are essential components of cell membranes, 
composed of a sphingosine molecule and up to two fatty acids, where one of these fatty 
acids is modified. 
 There are some contrasting opinions on the classification of the sizes of the 
carbon chain and thus the descriptive classification of the various fatty acids and 
monoglycerides. Generally, carbon chain lengths of six or less are referred to as short-
chain fatty acids, chain lengths of seven to twelve are medium-chain fatty acids, and 
carbon chains of 13 or greater are known as long-chain fatty acids (Osborn and Akoh 
2002). The carbon chain can also vary in complexity, but only straight chain 
(unbranched) fatty acids will be discussed in this review. 
After carbon chain length, the level of saturation of the carbon chain also has an 
effect on the physical properties of the molecule. Fatty acids with no double bonded 
carbons in their carbon chains are known as saturated fatty acids; these are the simplest 
fatty acids. Fatty acids that do have double carbons in their carbon chain are known as 
unsaturated fatty acids, as in, the carbons are not saturated with hydrogens. If only one 
double bond is present, then the term monounsaturated is sometimes used and fatty 
acids with more than one double bond are known as polyunsaturated. The double bond 
also creates another level of complexity which is manifested by giving rise to 
geometrical or configurational isomers (cis or trans isomers). The difference in physical 
properties between the two isomers is large. The trans form would make the molecule 
flatter, more like the straight carbon chain of an unsaturated carbon chain. The cis form 
on the other hand would make a more “bent” molecule. Polyunsaturated molecules with 
cis form double bonds therefore do not have straight carbon chains. This hinders the 
packing of molecules and can affect the melting temperature. The cis form of double 
bond is more common in nature. Although the trans form can occur in nature, it is more 
commonly associated with man-made processing for creating unsaturated fatty acid via 
hydrogenation. 
Antibacterial effects of fatty acids 
The antimicrobial properties of fatty acids have been reported in the scientific literature 
for over 100 years (Lamar 1911). With the advent of antibiotics, the antimicrobial 
properties of other discoveries were largely eclipsed. It was not until the 1970’s that 
interest in fatty acids saw its antibacterial activity rediscovered with the publication of 
more comprehensive studies of the action of fatty acids on bacteria (Kabara and Vrable 
1977). At that time, a range of Gram-positive and Gram-negative bacteria were exposed 
to both saturated and unsaturated fatty acids as well as monoglycerides, other esters, and 
amines. It was discovered that, against the bacteria investigated, lauric acid had the 
most potent antimicrobial properties of the saturated fatty acids and that linoleic and 
linolenic acids were the most potent of the unsaturated fatty acids. These findings of the 
antimicrobial effects of the different types of fatty acids mirrored what had previously 
been discovered for soaps and detergents. However, the exact trend in antibacterial 
activity varied between different research studies and the action of the fatty acids was 
believed to potentially be different between different organisms. 
Following on from these studies, more in-depth investigations have been 
conducted to try to determine the mechanism(s) of action of fatty acids and 
monoglycerides on particular microorganisms or specific groups of microorganisms 
(Miller et al. 1977; Kanetsuna 1985; Wang and Johnson 1992; Petschow et al. 1996; 
Bergsson et al. 1998; Bergsson et al. 1999; Bergsson et al. 2002; Sun et al. 2003; 
Churchward et al. 2017). These studies focused on including a greater number of 
bacterial strains than had been previously studied (Table 1).  At the present time, while 
there are standard techniques used to test antimicrobial activity, such as log reduction 
assays that determine the ability of a substance to kill statistically significant numbers of 
bacteria for the substance to be considered to be effective. However, there is no 
standardization of the parameters used in log reduction assays, such as concentration 
and time. Different research investigations have used different testing conditions and 
techniques, where some are better at reflecting the conditions of the site of infection, 
such as pH, and others are better at considering achievable concentrations and exposure 
times in vivo. All of experiments in Table 1 demonstrated effective killing of the 
bacterial species under the conditions listed, with at least a 4 log reduction in the 
number of bacteria following exposure to the fatty acid or monoglyceride. These 
different research studies have used different concentrations of fatty acids and 
monoglycerides, applied to the bacteria for different periods of time, in different pH 
conditions, and in different bacterial growth media, due to different growth 
requirements of the bacteria (Table 1). Such variations in methodology used in research 
in the field can hinder direct comparison of different studies. 
From these studies, three candidates emerge that have demonstrated 
antimicrobial activity against a range of different bacterial species across several 
experiments (Figure 1). Lauric acid, a 12 carbon fatty acid has been demonstrated in 
several studies to be antimicrobial against Mycobacterium smegmatis, Chlamydia 
trachomatis, Listeria monocytogenes, Staphylococcus aureus, Neisseria gonorrhoeae, 
and Helicobacter pylori (Figure 1 and Table 1), which is notable considering the wide 
variety in surface structures of these bacterial species. The monoglyceride of lauric acid, 
monolaurin, is antimicrobial against some of these species, but not all (Figure 1, Table 
1), as is the 10 carbon monoglyceride monocaprin. 
Antibacterial effects of monoglycerides: monocaprin or monolaurin? 
The monoglycerides monocaprin and/or monolaurin have been identified as being 
bactericidal in several studies (Table 1; Figure 1), however the results as to their 
effectiveness do not always agree. In some cases, the potency of the action of these 
monoglycerides has been many times greater than that of the fatty acids assayed. For 
example, monolaurin was shown to be over 200 times more effective at killing S. 
aureus and Streptococcus pyogenes than lauric acid, which has the same number of 
carbons, but lacks the glycerol present in the monoglyceride (Schlievert and Peterson 
2012). Monocaprin has been demonstrated to have the fastest and most effective killing 
action among a panel of fatty acids and monoglycerides tested against N. gonorrhoeae, 
including monolaurin (Bergsson et al. 1999; Churchward et al. 2017).  The different 
activity of monolaurin and monocaprin observed in the literature may be due to 
differences in the bacteria included in the studies, Gram-positive bacteria (Schlievert 
and Peterson 2012) versus Gram-negative (Bergsson et al. 1999 Churchward et al. 
2017), and/or the differences could be due to differences in methodology. 
 In addition to the bacterial species investigated, the time that the bacteria are 
exposed to the fatty acids and/or monoglycerides, the temperature at which the 
experiment is conducted, the pH of the culture, and the constituents of the culture 
medium itself all vary in each study (Table 1). These differences could account for why 
some research finds certain fatty acids and monoglycerides more effective than others. 
However, if the variable of bacterial species is removed, a clearer picture emerges. 
Three studies by three different research groups have investigated the activity of fatty 
acids and monoglycerides against H. pylori (Table 1). In all three, monocaprin and 
monolaurin were almost equal in their bactericidal properties. Differences observed 
between other investigations are therefore most likely to be because one has greater 
activity over the other when tested against a certain bacterial species. 
Antiviral properties of fatty acids and monoglycerides 
The antiviral properties of a variety of fatty acids were examined in the 1980’s (Kohn et 
al. 1980). It was demonstrated that certain fatty acids inhibited enveloped viruses such 
as herpes simplex, influenza, Sendai, and Sindbis viruses. However, all of the non-
enveloped viruses investigated, including polio, Simian virus 40, and 
encephalomyocarditis virus were still active after treatment. The fatty acids found to be 
antiviral as a result of this research were oleic, arachidonic, and linoleic acid. Based on 
the experimental results, it was concluded that inactivation was due to disruption of the 
viral envelope, which was demonstrated by electron-micrograph (Kohn et al. 1980). In a 
separate study, oleic acid, linoleic acid, capric acid, lauric acid, and myristic acid were 
shown to also be antiviral against vesicular stomatitis virus, herpes simplex virus type 1, 
and Visna virus. These viruses were also inactivated by monoglycerides monocaprylin, 
monocaprin, and monolaurin (Thormar et al. 1994). 
 The lipids present in human breast milk were shown to have antiviral activity, 
having the ability to inactivate enveloped viruses in a manner similar to what is seen 
with fatty acids (Thormar et al. 1987). This study demonstrated that the naturally 
occurring lipases in human breast milk were able to release free fatty acids and 
monoglycerides, contributing to the antiviral activity. 
Mechanism of antimicrobial action 
It remains unclear the precise mechanism of action involved in the antimicrobial 
properties of fatty acids and monoglycerides. Indeed, different bacteria and viruses may 
be inactivated via different mechanisms. A number possible targets for fatty acids and 
monoglycerides have been identified (Desbois and Smith 2010). After one hour of 
exposure to 10 mM arachidonic acid, many morphological changes can be observed in 
N. gonorrhoeae and Haemophilus influenzae, including separation of inner and outer 
membranes, loss of cell shape, and complete cell disorganisation and disruption (Knapp 
and Melly 1986). This may be due to the amphiphilic nature of fatty acids and 
monoglycerides; at high concentrations they may act as a detergent and aid the 
solubilisation of the lipids in the membranes causing cell lysis. Quartz crystal 
microbalance-dissipation (QCM-D) and fluorescence microscopy has been applied to 
examine the action of lauric acid, lauryl sulfate, monolaurin, capric acid, and 
monocaprin on the destabilisation of the bacterial lipid bilayers that make up the 
bacterial cell membrane (Yoon et al. 2015; Yoon et al. 2017). These studies showed that 
the antimicrobials had a different effects upon the lipid bilayer, with lauric acid, lauryl 
sulfate, and capric acid causing tubule formation, lauryl sulfate and monocaprin 
ultimately causing complete bilayer solubilisation, monolaurin causing spherical 
protrusions from the lipid bilayer, and monocaprin causing tubules or buds. These 
results suggest that not all fatty acids and their derivatives disrupt bacterial membranes 
in the same way, even when the carbon chain lengths are the same. All tested 
compounds acted at or above the critical micelle concentration (CMC), with 
monocaprin also having an impact below the CMC where tubules are formed, as 
opposed to membrane buds (Yoon et al. 2017). The anionic surfactants, lauric acid and 
lauryl sulfate, produced more membrane strain than the non-ionic monolaurin, however 
the concentration of monolaurin needed to disturb the membrane is lower (Yoon et al. 
2015). The targeting of membranes as a main mechanism of antimicrobial activity 
explains why fatty acids and monoglycerides have only been shown to inactivate 
enveloped viruses and not non-enveloped viruses. 
 Evidence supports the concept that the action of fatty acids and their derivatives 
is more than simple insertion into the bacterial membrane. Membrane remodelling is 
noted in the presence of docosahexaenoic acid, an unsaturated 22 carbon omega-3 fatty 
acid, which was used to demonstrate the utility of QCM-D for studying membrane 
changes (Thid et al. 2007). Often QCM-D studies use pure phospholipids, but recent 
studies have also investigated mixtures of phospholipids and cholesterols to investigate 
the influence of membrane cholesterol presence on  remodelling by sodium dodecyl 
sulfate, lauric acid, and glycerol monolaurate (Kawakami et al. 2017). As with previous 
studies, the remodelling is specific to the fatty acid or derivative added, yet these results 
also show that it is dependent on cholesterol concentrations in the membrane as well 
(Kawakami et al., 2017). These results support continued research into fatty acids and 
monoglycerides as alternative antimicrobials. 
 In a study looking at food poisoning, the Gram-negative pathogen E. coli, the 
Gram-positive nonpathogen Staphylococcus xylosus used in creating fermented 
sausages, and the food spoilage yeast Zygosaccharomyces bailii were used to 
investigate the mode of action of monocaprylate (Hyldgaard et al. 2012). 
Monocaprylate integrated into the cell membranes and increased membrane 
permeability. It was demonstrated that the membrane fluidity and phospholipid 
composition of microorganisms are the key factors determining susceptibility to fatty 
acids and their derivatives (Hyldgaard et al. 2012). It is interesting to note here that E. 
coli was less susceptible to monocaprylate at 15°C, emphasizing the importance of 
temperature. Both the bacterial membrane fluidity and composition and the solubility of 
monocaprylate will change at lower temperatures (Hyldgaard et al. 2012). 
At lower concentrations, fatty acids and monoglycerides can inhibit microbial 
growth by preventing cell division. In this way, the antimicrobials are interfering with 
essential cell processes, and there are a number of theories about how. Inhibition of cell 
division could be due to loss of cellular contents through a membrane with increased 
permeability due to the fatty acids / monoglycerides. Although this does not kill the cell, 
the loss of material from the cell arrests division. It is also possible that cell division 
could be inhibited due to fatty acid / monoglyceride interaction with intracellular 
target(s). 
Inhibition of the electron transport system, based in the inner membrane, may be 
responsible in part for the growth inhibition observed by N. gonorrhoeae when exposed 
to various fatty acids (Miller et al. 1977). It is hypothesized that, membrane-bound 
protein complexes in the inner membrane involved in the electron transport chain could 
be inhibited by the presence of the fatty acid / monoglyceride outside of the cell, 
therefore passage through the outer membrane, peptidoglycan layer, and periplasm may 
not be required. Fatty acids / monoglycerides could also or alternatively interfere with 
other membrane-bound cellular processes, such as nutrient uptake or enzyme inhibition 
(Desbois and Smith 2010). Another possible mechanism of action, which would require 
entry of the antibacterial into the cell, is the inhibition the biosynthesis of fatty acids 
inside the bacterial cell itself (Zheng et al. 2005; Sado-Kamdem et al. 2009). Inhibition 
of fatty acid biosynthesis has long been a desired target of pharmaceutical companies as 
it offers a target not used by existing antimicrobials, so there is little chance of cross 
resistance (Parsons and Rock 2011). 
Factors effecting antimicrobial activity 
The most common environmental variable that is analysed when assessing the activity 
of fatty acids and monoglycerides is pH. This variable is often included in the 
experimental design if the particular organism of interest inhabits an environment with a 
low, high, or variable pH, such as, for example, investigating the effects of fatty acids 
on H. pylori (Sun et al. 2003). There is a trend with fatty acids that generally the 
minimum inhibitory concentration (MIC) of shorter chain fatty acids (6-10) increase 
with increases in pH and that the MIC of medium chain fatty acids (12-14) decreases 
with increases in pH. The effect of pH on the antimicrobial properties of longer chain 
fatty acids and monoglycerides is less prominent. However, monoglycerides are prone 
to saponification in the presence of a metal base. 
 Another commonly altered experimental variable is the time that the bacteria or 
viruses are exposed to the antimicrobial fatty acids and monoglycerides. Some research 
has demonstrated that fatty acids and monoglycerides have fast acting antimicrobial 
properties, killing in as little as one minute (Bergsson et al. 1999), while much longer 
incubation times are seen in other experiments. For H. pylori, studies using 10 minutes 
of incubation (Bergsson et al. 2002) gave similar levels of susceptibility to those 
incubated for one hour (Petschow et al. 1996). These two studies also included other 
experimental differences, however in the absence of a detailed pharmacodynamics 
study, the comparable results indicate that bactericidal activity is not heavily time-
dependant. This supports the theory that membrane disruption is the main cause of 
bactericidal activity. Cell death would be dependent on cell lysis, which would be 
almost instantaneous after cell membrane disruption. The concentration of freely 
available fatty acid / monoglyceride to cause cell disruption is the crucial factor in 
killing, rather than the amount of time exposed. 
The presence of certain divalent metal ions has a pronounced effect on the action 
of some fatty acids. Magnesium and calcium ions were investigated for their inhibitory 
effects of the fatty acid on bacterial growth (Galbraith et al. 1971). Growth rates of 
selected Gram-positive bacteria incubated with either linoleic acid or lauric acid were 
observed to determine if the presence of magnesium or calcium ions could reverse the 
bacteriostatic effects of the fatty acids. Lauric acid had the greatest inhibitory power 
from the two fatty acids, but its action was reversed by the presence of magnesium or 
calcium ions. The mono-unsaturated linoleic acid was only affected by the action of the 
calcium and not by the magnesium. No such reversal by magnesium and calcium ions 
was observed in experiments on Mycobacterium species using various fatty acids 
(Kanetsuna 1985). Recent research into the use of monocaprin against ocular infections 
by N. gonorrhoeae has shown that the presence of calcium in tear fluid reduced the 
antibacterial properties of palmitoleic acid and linolenic acid and negated the effects of 
lauric acid, sodium dodecanoate, and tridecanoic acid (Churchward et al. 2017). 
Serum has a strong reversal effect in some cases. In Mycobacterium species, 2% 
serum reduces the action of the fatty acids by two to four times, in a pH dependant 
manner (Kanetsuna 1985). Serum was also demonstrated to reverse the effects of 
linolenic acid on S. aureus (Lacey and Lord 1981). Serum is known to reduce the 
activity of disinfectants, so its inhibition of fatty acids and monoglycerides is not 
surprising (Coates 1988). Some H. pylori growth media includes 5% bovine serum, 
however the results obtained with such media were similar to those of other researchers 
(Sun et al. 2007). This suggests that the reversal effects of serum on the fatty acids may 
be complex and depends upon the fatty acid / monoglyceride being tested and / or the 
species of bacteria being investigated.  
Mechanisms of resistance 
Fatty acids and monoglycerides do not have bactericidal action against all bacterial 
species (Galbraith et al. 1971; Kabara and Vrable 1977). Generally speaking, more 
Gram-positive species are prone to their killing action than Gram-negative bacterial 
species. As described, the main target of the fatty acid / monoglyceride is believed to be 
the cell membrane, therefore, anything that prevents access to this target will inhibit 
their action. In Gram-positive bacteria, it has been demonstrated that Streptococcus 
pneumoniae is more susceptible to the bactericidal effects of fatty acids and 
monoglycerides than S. aureus, which is more susceptible than Bacillus subtilis (Kabara 
et al. 1972; Bergsson et al. 2001). These differences in susceptibility could be due to 
differences within the peptidoglycan layer in these three bacterial species, such as the 
amount of teichoic acid present, which may inhibit the action of the fatty acid / 
monoglyceride (Kohler et al. 2009). 
Gram-negative bacteria are more likely to be resistant to the effects of fatty acids 
and monoglycerides, presumably due to the presence of an outer membrane. The protein 
content and lipopolysaccharide (LPS) structure in the outer membrane can vary greatly 
between different Gram-negative species (Gibson et al. 1993). Despite this, some Gram-
negative bacterial species are susceptible. Neisseria (Miller et al. 1977; Knapp and 
Melly 1986; Bergsson et al. 1999; Churchward et al. 2017), Haemophilus (Knapp and 
Melly 1986; Isaacs et al. 1995; Schlievert PM, Peterson), Moraxella (Knapp and Melly 
1986), Chlamydia (Bergsson et al. 1998), Helicobacter (Petschow et al. 1996; Bergsson 
et al. 2002; Sun et al. 2003; Sun et al. 2007; Roberton et al. 2008), and Campylobacter 
(Hilmarsson et al. 2006; Hermans et al. 2010; Thormar et al. 2010; Thormar et al. 2011) 
are the only Gram-negative species shown to be susceptible to fatty acids and 
monoglycerides. Neisseria and Haemophilus species are each susceptible to a range of 
fatty acids and monoglycerides and unlike the intrinsically resistant Enterobacteriaceae, 
have different LPS structures that may account for this susceptibility. Both Neisseria 
and Haemophilus lack the repeating polysaccharide O-antigen found in other Gram-
negative species and instead have a highly variable and branched core oligosaccharide 
region. These structures are so different from other LPSs that they are often 
differentiated by referring to them as lipooligosaccharides (LOS) (Yamasaki et al. 
1994). The LPS O-antigen of other Gram-negatives is made of a chain of hydrophilic 
sugars; the longer the chain the less lipophilic the outer membrane. In fact, bacteria 
expressing a shorter form of O-antigen are more permeable to hydrophobic 
antimicrobials (Tsujimoto et al. 1999).   
Within the genus Neisseria, there are two pathogenic species: N. gonorrhoeae 
and N. meningitidis. These bacteria are very similar genetically but have different 
strategies for fatty acid / monoglyceride resistance. Both pathogens have the FarA-
FarB-MtrE efflux system that actively transports long chain fatty acids from the 
periplasmic space back outside the outer membrane (Shafer et al. 2001). The Fatty Acid 
Resistance (Far) efflux pump has FarA in the inner membrane and FarB in the 
periplasmic space, attached to FarA and also to MtrE in the outer membrane (Lee and 
Shafer 1999; Lee et al. 2003). This efflux system has been demonstrated to increase 
resistance 8 to 32 times for long chain fatty acids such as linoleic acid, oleic acid, and 
palmitic acid (Lee and Shafer 1999). In addition, the structure of the core 
oligosaccharide and hexa-acylation of its membrane anchor lipid A contributes to 
additional fatty acid resistance in N. meningitidis (Schielke et al. 2010). This highlights 
the importance of the role of the LPS / LOS structure in fatty acid / monoglyceride 
resistance in Gram-negative bacteria. Although Neisseria and Haemophilus share some 
features, including LOS and similar multi-drug efflux pumps, no fatty acid efflux pump 
has been identified in Haemophilus. 
Potential uses of fatty acids and monoglycerides 
Fatty acids and monoglycerides have an expansive range of possible applications in 
medicine, food safety, agriculture, cosmetics, and personal hygiene products (Desbois 
and Smith 2010; Desbois 2012). As reports around the world of multi-antibiotic 
resistant bacteria increase, it is evident that the time is fast approaching when key 
bacterial pathogens will be resistant to currently used antibiotics (Alanis 2005; Unemo 
et al. 2016; Jones et al. 2017). Fatty acids and monoglycerides offer alternative 
treatment options, either alone or in combined therapy with existing antimicrobials to 
improve their effectiveness. It has been shown that certain unsaturated fatty acids can 
act as inhibitors of bacterial conjugation, a mechanism whereby some bacteria can 
acquire antibiotic resistance genes (Fernandez-Lopez et al. 2005). Preventing this 
process by use of these unsaturated fatty acids could help reduce the spread of acquired 
resistance. 
Fatty acids and monoglycerides may have an effect upon toxin production, a key 
virulence factor in some bacterial infections. Monolaurin, for example, reduces the 
levels of toxins produced by S. aureus (Schlievert et al. 1992; Peterson and Schlievert 
2006). Topical pharmaceutical products could combine antimicrobials with mild 
antiseptics such as the blend of chlorhexidine dihydrochloride (antiseptic) and 
neomycin (antibiotic) in the nasal cream Naseptin® (Stokes and Milne 1962). 
Furthermore, fatty acids and monoglycerides have been shown to be synergistic with 
standard antimicrobials such as aminoglycosides on bacteria and even on pre-
established bacterial biofilms (Davies and Marques, 2009; Schlievert and Peterson 
2012; Hess et al. 2014; Sepehr et al. 2014).  
Fatty acids and monoglycerides could also be used in the future to aid in the 
prevention of foodborne campylobacteriosis, food poisoning caused by Campylobacter 
bacteria. By adding monocaprin to feed and water of broiler chickens, the bacterial load 
in these birds may be reduced (Hilmarsson et al. 2006) and thereafter the poultry 
carcases could be washed with monocaprin (Thormar et al. 2011), as could the chopping 
boards and surfaces used to handle the meat (Thormar and Hilmarsson 2010). The later 
of these two suggestions may offer the greatest potential, as the addition of monocaprin 
to feed and water produced variable results and it has been shown that intestinal mucus 
may inhibit medium chain fatty acids and monoglycerides such as monocaprin 
(Hermans et al. 2010). 
Potential medical treatments suggested in the research literature include a 
monocaprin based hydrogel for prevention of sexually transmitted bacterial infections 
(Thormar et al. 1999; Kristmundsdottir et al. 1999; Neyts et al. 2000; Kristmundsdottir 
et al. 2003), a monocaprin based cream for the treatment of viral cold sores 
(Thorgeirsdottir et al. 2005; Thorgeirsdottir et al. 2006), the use of fatty acids for the 
prevention of gastric ulcers caused by H. pylori (Roberton et al. 2008), the use of a fatty 
acid microemulsion against S. aureus (Butt et al. 2016), and a monocaprin or 
myristoleic acid eye drop against N. gonorrhoeae ophthalmia neonatorum infant eye 
infections (Churchward et al. 2017). It has been suggested that fatty acids and 
monoglycerides could play a valuable role in wound care (Ferreira et al. 2012). 
Additionally, it has been proposed that fatty acids and their cholesteryl esters could be 
packaged into liposomes (Cheung et al. 2016), lipid nanocapsules (Umerska et al. 
2016), or other nanotechnology formulations (Jackman et al. 2016) to enhance the 
activity of antibiotics. 
 
Conclusions 
It is clear that fatty acids and monoglycerides have strong antimicrobial properties that 
could be very useful in many applications beneficial to the health and wellbeing of 
humans. In particular, with the ever increasing levels of antibiotic resistance, fatty acids 
and monoglycerides could play a role in treatment or preventative medicine for bacterial 
infections. However, there are limitations to the use of fatty acids or monoglycerides 
including the lack of any great selective toxicity, and the reversal of antimicrobial 
activity by neutralising agents that may be naturally present. These factors will need to 
be addressed in explorations into the therapeutic application of the fatty acids and 
monoglycerides. 
 The lack of standardised methods for the investigation of fatty acids and 
monoglycerides has also hampered progress in this field. Some guidelines to aid in 
experimental design and testing of products against bacteria and viruses would aid in 
the interpretation of results across different studies. We suggest here that log reduction 
assays should be conducted at the temperature appropriate for infection of the host, 
demonstrating activity at the physiological temperature. A range of times from 1 minute 
to 24 hours should be investigated to determine how rapid killing can be achieved. The 
relevant physiological pH or range of pHs should be used for the log reduction assays 
and ideally, the activity of the fatty acid or monoglyceride against the bacteria should be 
determined using a media that is physiologically relevant. Most importantly, the details 
of the conditions under which the experiments are conducted, including temperature, 
time, pH, and media composition, must be reported in the literature. By understanding 
the differences between studies, bacteria, and viruses, we may gain a better 
understanding of the mechanisms of action and therefore the ways in which different 
fatty acids and monoglycerides can be used to combat infection. The existence of 
registered patents describing the use of fatty acids and monoglycerides in medical 
products may suggest that these alternative antimicrobials will be put into application in 
the near future. 
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Table 1. Antibacterial killing activity of fatty acids and monoglycerides at 37°C. 
Organism Most effective 
fatty acid or 
monoglyceride 
Log reduction assay 
conditions, demonstrating 
bacterial killing~ 
Reference 
Chlamydia 
trachomatis 
Capric acid 
Lauric acid 
Monocaprin 
20 mM for 5 minutes 
10 mM for 10 minutes 
5 mM for 5 minutes 
Bergsson et 
al. 1998 
Helicobacter pylori Lauric acid 
Monocaprin 
Monolaurin 
Monocaprylin 
1 mM for 1 hour 
1 mM for 1 hour 
1 mM for 1 hour 
5 mM for 1 hour 
Petschow et 
al. 1996 
Lauric acid 
Linolenic acid 
Monolaurin 
Monomyristin 
1 mM for 40 minutes* 
0.5 mM for 40 minutes* 
0.5 mM for 40 minutes* 
0.9 mM for 40 minutes* 
Sun et al. 
2003 
Lauric acid 
Palmitoleic acid 
Monocaprin 
Monolaurin 
1.25 mM for 10 minutes 
1.25 mM for 10 minutes 
1.25 mM for 1 minutes 
1.25 mM for 1 minutes 
Bergsson et 
al. 2002 
Listeria 
monocytogenes 
Lauric acid 
Linolenic acid 
Monolaurin 
20 µg/ml for 24 hours† 
10 µg/ml for 24 hours‡ 
100 µg/ml for 24 hours† 
20 µg/ml for 24 hours‡ 
10 µg/ml for 24 hours† 
10 µg/ml for 24 hours‡ 
Wang and 
Johnson 
1992 
Mycobacterium 
smegmatis 
Lauric acid 
Myristic acid 
0.2 mM for 20 minutes‡ 
 
 
0.2 mM for 20 minutes†^ 
Kanetsuna 
1985 
Palmitoleic acid 
Oleic acid 
 
0.2 mM for 20 minutes†^ 
 
0.1 mM for 20 minutes†^ 
Neisseria 
gonorrhoeae 
Lauric acid 
Palmitoleic acid 
Monocaprin 
Monolaurin 
2.5 mM for 1 minute 
2.5 mM for 1 minute 
2.5 mM for 1 minute 
2.5 mM for 1 minute 
Bergsson et 
al. 1999 
Myristoleic acid 
Palmitoleic acid 
Linolenic acid 
Monocaprin 
0.5 mM for 2 minutes 
0.5 mM for 2 minutes 
0.5 mM for 2 minutes 
0.5 mM for 2 minutes 
Churchward 
et al. 2017 
Staphylococcus 
aureus 
Lauric acid 
Monolaurin 
0.25 mM for 24 hours 
0.25 mM for 24 hours 
Schlievert 
and 
Peterson 
2012 
 
~ Conditions under which log reduction assays were conducted and for which there was 
at least a 4 log reduction in viable bacteria, the standard for effective bacterial killing. 
* Conducted at 37 °C pH 7.4 in medium containing 5 % horse serum. 
† Conducted at pH 6.0. 
‡ Conducted at pH 5.0. 
^ Conducted at pH 7.0. 
  
  
Figure 1. Activity of antimicrobial fatty acid and monoglycerides against bacteria 
species. Shown here are the structures of the antimicrobial fatty acid lauric acid, its 
monoglyceride monolaurin and the monoglyceride of capric acid, monocaprin, which 
are frequently investigated for antibacterial killing activity (see Table 1). These have 
overlapping antimicrobial activity against unrelated bacterial species, as shown, with all 
three being active against Neisseria gonorrhoeae and Helicobacter pylori, monolaurin 
also being active against Staphylococcus aureus and Listeria monocytogenes, 
monocaprin also being active against Chlamydia trachomatis, and lauric acid being 
effective at killing all of these bacteria and also Mycobacterium smegmatis. 
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